Picture of Sunrest Lifescience logo

SUNREST Sunrest Lifescience Cashflow Statement

0.000.00%
in flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Annual cashflow statement for Sunrest Lifescience, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

2021
March 31st
2022
March 31st
2023
March 31st
Period Length:12 M12 M12 M
Source:PROSPECTUSPROSPECTUSPROSPECTUS
Standards:
IAS
IAS
IAS
Status:FinalFinalFinal
Net Income/Starting Line2.2410.527.4
Depreciation
Non-Cash Items0.076-0.1160.591
Unusual Items
Other Non-Cash Items
Changes in Working Capital-1.21-15.5-17.8
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities1.53-4.4911.5
Capital Expenditures-1.62-4.67-0.142
Purchase of Fixed Assets
Other Investing Cash Flow Items1.1-0.165
Sale of Fixed Assets
Purchase of Investments
Cash from Investing Activities-1.62-3.56-0.307
Financing Cash Flow Items-0.075-0.108-0.591
Other Financing Cash Flow
Net Issuance / Retirement of Debt
Cash from Financing Activities0.3819.12-11.5
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash0.2961.07-0.301